Evaluating the mouse neural precursor line, SN4741, as a suitable proxy for midbrain dopaminergic neurons

Area of Science:

• Neuroscience
• Genomics
• Cell Biology

Background:

• * In vitro models are crucial for studying human diseases like Parkinson disease when in vivo models are limited.
• * The SN4741 mouse neural precursor cell line has been used for over 25 years to study Parkinson disease neurotoxicity.
• * Contemporary genomic characterization is needed to validate the suitability of established in vitro models.

Approach:

• * Employed karyotyping, RT-qPCR, single-cell RNA-seq, bulk RNA-seq, and ATAC-seq to analyze SN4741 cells.
• * Assessed transcriptional and chromatin landscapes, and genomic architecture.
• * Compared SN4741 cell profiles to ex vivo dopaminergic neurons.

Key Points:

• * SN4741 cells exhibit unstable triploidy and low expression of dopaminergic neuron markers.
• * Transcriptional analysis indicates differentiation into immature neurons, not dopaminergic precursors.
• * Chromatin landscapes do not align with those of authentic dopaminergic neurons.

Conclusions:

• * SN4741 cells may model early neuronal differentiation but are not a suitable proxy for dopaminergic neurons in Parkinson disease research.
• * Highlights the necessity for robust genomic validation of in vitro disease models.
• * Underscores the importance of understanding model system limitations for accurate research findings.